SCHLXETF / FundDWS Health and Wellness Fund
Verdicts genuinely change. Free email alert the moment SCHLX's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
DWS Health and Wellness Fund · DEUTSCHE DWS SECURITIES TRUST
65 holdings
NON-COMPLIANT 13.36% of portfolio weight is in non-compliant holdings, over the 5% threshold.
65 holdings, 59 matched (96% of weight). Portfolio as of 2026-08-31, filed 2026-10-26. Source: SEC Form N-PORT.
0.85% of this portfolio’s income is non-permissible — weighted across holdings, computed over 86% of portfolio weight (53 of 65 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
83.0% compliant 0.0% questionable 13.4% non-compliant 3.6% unscreened
All holdings (65)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY Eli Lilly & Co | COMPLIANT | 12.35% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| JNJ Johnson & Johnson | COMPLIANT | 6.33% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| MRK Merck & Co Inc | COMPLIANT | 5.29% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 5.00% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| ABBV AbbVie Inc | COMPLIANT | 4.91% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 3.76% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| AMGN Amgen Inc | COMPLIANT | 3.18% | AAOIFI24.9% Usmani59.9% Dow Jones Islamic33.6% S&P Shariah35.1% MSCI Islamic59.9% MSCI Islamic M-Series35.1% FTSE Shariah59.9% |
| AZN AstraZeneca PLC | COMPLIANT | 2.88% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| NVS Novartis AG | COMPLIANT | 2.77% | AAOIFI12.5% Usmani25.9% Dow Jones Islamic11.8% S&P Shariah12.6% MSCI Islamic25.9% MSCI Islamic M-Series12.6% FTSE Shariah25.9% |
| ABT Abbott Laboratories | COMPLIANT | 2.67% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| GILD Gilead Sciences Inc | COMPLIANT | 2.62% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| VRTX Vertex Pharmaceuticals Inc | COMPLIANT | 2.58% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| SYK Stryker Corp | COMPLIANT | 2.40% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| DHR Danaher Corp | COMPLIANT | 2.16% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| RO.SW Roche Holding AG | COMPLIANT | 2.14% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| MCK McKesson Corp | COMPLIANT | 2.12% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| ISRG Intuitive Surgical Inc | COMPLIANT | 2.07% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| BMY Bristol-Myers Squibb Co | NON_COMPLIANT | 1.75% | AAOIFI37.3% Usmani51.1% Dow Jones Islamic42.2% S&P Shariah44.8% MSCI Islamic51.1% MSCI Islamic M-Series44.8% FTSE Shariah48.9% |
| MDT Medtronic PLC | COMPLIANT | 1.64% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| DWS | UNSCREENED | 1.62% | no in-house ratios for this holding |
| REGN Regeneron Pharmaceuticals Inc | COMPLIANT | 1.61% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| BSX Boston Scientific Corp | COMPLIANT | 1.50% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| NOVO-B.CO Novo Nordisk A/S | COMPLIANT | 1.50% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| CAH Cardinal Health Inc | COMPLIANT | 1.39% | AAOIFI17.8% Usmani17.7% Dow Jones Islamic24.8% S&P Shariah28.7% MSCI Islamic17.4% MSCI Islamic M-Series28.7% FTSE Shariah15.5% |
| COR Cencora Inc | COMPLIANT | 1.31% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| PFE Pfizer Inc | NON_COMPLIANT | 1.15% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| A Agilent Technologies Inc | COMPLIANT | 1.14% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| IQV IQVIA Holdings Inc | NON_COMPLIANT | 1.11% | AAOIFI36.7% Usmani55.2% Dow Jones Islamic47.8% S&P Shariah44.8% MSCI Islamic54.4% MSCI Islamic M-Series44.8% FTSE Shariah53.4% |
| ARGX Argenx SE | COMPLIANT | 1.09% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| BIIB Biogen Inc | COMPLIANT | 0.90% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| BDX Becton Dickinson & Co | NON_COMPLIANT | 0.86% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| RMD ResMed Inc | COMPLIANT | 0.84% | AAOIFI2.6% Usmani9.2% Dow Jones Islamic2.4% S&P Shariah2.6% MSCI Islamic9.2% MSCI Islamic M-Series2.6% FTSE Shariah7.4% |
| DXCM Dexcom Inc | COMPLIANT | 0.78% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| ALC Alcon AG | COMPLIANT | 0.74% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| EW Edwards Lifesciences Corp | COMPLIANT | 0.73% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| RadNet Inc | UNSCREENED | 0.71% | no in-house ratios for this holding |
| NBIX Neurocrine Biosciences Inc | COMPLIANT | 0.66% | AAOIFI2.9% Usmani8.6% Dow Jones Islamic3.4% S&P Shariah3.5% MSCI Islamic8.6% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| WAT Waters Corp | COMPLIANT | 0.65% | AAOIFI14.1% Usmani21.2% Dow Jones Islamic21.2% S&P Shariah23.3% MSCI Islamic21.2% MSCI Islamic M-Series23.3% FTSE Shariah19.7% |
| IDXX IDEXX Laboratories Inc | COMPLIANT | 0.64% | AAOIFI1.4% Usmani16.8% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic16.8% MSCI Islamic M-Series1.3% FTSE Shariah13.1% |
| WST West Pharmaceutical Services Inc | COMPLIANT | 0.64% | AAOIFI1.3% Usmani7.8% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic7.7% MSCI Islamic M-Series1.4% FTSE Shariah5.0% |
| SNY Sanofi SA | COMPLIANT | 0.63% | AAOIFI20.8% Usmani14.7% Dow Jones Islamic38.1% S&P Shariah38.6% MSCI Islamic14.7% MSCI Islamic M-Series38.6% FTSE Shariah14.7% |
| Hoya Corp | UNSCREENED | 0.63% | no in-house ratios for this holding |
| ALNY Alnylam Pharmaceuticals Inc | COMPLIANT | 0.63% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| INCY Incyte Corp | COMPLIANT | 0.58% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| VEEV Veeva Systems Inc | NON_COMPLIANT | 0.56% | AAOIFI0.4% Usmani1.7% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic1.7% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| ZTS Zoetis Inc | NON_COMPLIANT | 0.55% | AAOIFI29.0% Usmani61.3% Dow Jones Islamic15.4% S&P Shariah14.0% MSCI Islamic61.3% MSCI Islamic M-Series14.0% FTSE Shariah60.0% |
| NTRA Natera Inc | COMPLIANT | 0.54% | AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0% |
| GEHC GE HealthCare Technologies Inc | NON_COMPLIANT | 0.52% | AAOIFI34.9% Usmani28.5% Dow Jones Islamic30.2% S&P Shariah30.1% MSCI Islamic28.4% MSCI Islamic M-Series30.1% FTSE Shariah27.3% |
| CNC Centene Corp | NON_COMPLIANT | 0.51% | AAOIFI50.5% Usmani19.4% Dow Jones Islamic62.6% S&P Shariah53.4% MSCI Islamic19.4% MSCI Islamic M-Series53.4% FTSE Shariah19.4% |
| HUM Humana Inc | NON_COMPLIANT | 0.45% | AAOIFI30.1% Usmani26.3% Dow Jones Islamic44.9% S&P Shariah38.8% MSCI Islamic26.3% MSCI Islamic M-Series38.8% FTSE Shariah25.3% |
| LH Labcorp Holdings Inc | COMPLIANT | 0.43% | AAOIFI25.4% Usmani36.5% Dow Jones Islamic31.6% S&P Shariah33.5% MSCI Islamic36.2% MSCI Islamic M-Series33.5% FTSE Shariah31.6% |
| Insmed Inc | UNSCREENED | 0.38% | no in-house ratios for this holding |
| ILMN Illumina Inc | COMPLIANT | 0.37% | AAOIFI1.6% Usmani8.1% Dow Jones Islamic2.7% S&P Shariah2.7% MSCI Islamic8.1% MSCI Islamic M-Series2.7% FTSE Shariah0.0% |
| BMRN BioMarin Pharmaceutical Inc | NON_COMPLIANT | 0.36% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| PRVA Privia Health Group Inc | NON_COMPLIANT | 0.32% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic0.6% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| PODD Insulet Corp | COMPLIANT | 0.30% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| COO Cooper Cos Inc/The | COMPLIANT | 0.28% | AAOIFI23.0% Usmani20.1% Dow Jones Islamic16.7% S&P Shariah15.5% MSCI Islamic20.1% MSCI Islamic M-Series15.5% FTSE Shariah20.1% |
| Revolution Medicines Inc | UNSCREENED | 0.28% | no in-house ratios for this holding |
| SDZ.SW Sandoz Group AG | COMPLIANT | 0.26% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| TECH Bio-Techne Corp | COMPLIANT | 0.25% | AAOIFI2.5% Usmani11.2% Dow Jones Islamic3.0% S&P Shariah2.9% MSCI Islamic11.2% MSCI Islamic M-Series2.9% FTSE Shariah7.7% |
| GMED Globus Medical Inc | COMPLIANT | 0.25% | AAOIFI1.1% Usmani2.0% Dow Jones Islamic1.1% S&P Shariah1.2% MSCI Islamic2.0% MSCI Islamic M-Series1.2% FTSE Shariah0.0% |
| EL.PA EssilorLuxottica SA | COMPLIANT | 0.24% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| UTHR United Therapeutics Corp | NON_COMPLIANT | 0.23% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| RGEN Repligen Corp | COMPLIANT | 0.22% | AAOIFI7.3% Usmani23.4% Dow Jones Islamic8.8% S&P Shariah8.4% MSCI Islamic23.4% MSCI Islamic M-Series8.4% FTSE Shariah18.7% |
| CONTRA APELLIS PHARMAC | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 40 points of portfolio weight — 79.1% of it passes AAOIFI, 39.1% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 79.1% ratios fail on 8.7% 12.1% not rated under AAOIFI
ratios pass on 44.9% ratios fail on 42.9% 12.1% not rated under Usmani
ratios pass on 69.1% ratios fail on 16.0% 14.9% not rated under Dow Jones Islamic
ratios pass on 72.1% ratios fail on 12.9% 14.9% not rated under S&P Shariah
ratios pass on 39.1% ratios fail on 48.6% 12.3% not rated under MSCI Islamic
ratios pass on 70.7% ratios fail on 14.3% 14.9% not rated under MSCI Islamic M-Series
ratios pass on 44.7% ratios fail on 40.3% 14.9% not rated under FTSE Shariah
59 of 65 listed holdings carry our own per-methodology verdicts (96% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 49 (82% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group Inc | 5.00% |
| BMY Bristol-Myers Squibb Co | 1.75% |
| PFE Pfizer Inc | 1.15% |
| IQV IQVIA Holdings Inc | 1.11% |
| BDX Becton Dickinson & Co | 0.86% |
| VEEV Veeva Systems Inc | 0.56% |
| ZTS Zoetis Inc | 0.55% |
| GEHC GE HealthCare Technologies Inc | 0.52% |
| CNC Centene Corp | 0.51% |
| HUM Humana Inc | 0.45% |
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
DWS Health and Wellness Fund (SCHLX) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Screened on its holdings, not its name
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| LLYEli Lilly & Co | 12.35% | Compliant |
| JNJJohnson & Johnson | 6.33% | Compliant |
| MRKMerck & Co Inc | 5.29% | Compliant |
| UNHUnitedHealth Group Inc | 5.00% | Non-compliant |
| ABBVAbbVie Inc | 4.91% | Compliant |
| TMOThermo Fisher Scientific Inc | 3.76% | Compliant |
| AMGNAmgen Inc | 3.18% | Compliant |
| AZNAstraZeneca PLC | 2.88% | Compliant |
| NVSNovartis AG | 2.77% | Compliant |
| ABTAbbott Laboratories | 2.67% | Compliant |
Top 10 of 65 holdings, 49.1% of the fund by weight. Every holding is screened, not only these.
What holds the number back
The positions keeping this fund short of 100% compliant by weight.
- UNHnon-compliant5.00%
- BMYnon-compliant1.75%
- DWSnot screened1.62%
- PFEnon-compliant1.15%
- IQVnon-compliant1.11%
- BDXnon-compliant0.86%
What changed, and when
Verdict history for SCHLX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for SCHLX has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
ℹ️ no compliance scan has run for 5 days - this is not a reading of today
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 72.80 | SELL |
| Stochastic %K (14) | 100.00 | SELL |
| CCI (20) | 132.31 | SELL |
| Williams %R (14) | 0.00 | SELL |
| MACD (12,26,9) | 0.23 | BUY |
| ROC (10) | 5.00 | BUY |
| Momentum (10) | 2.33 | BUY |
| EMA (10) | 47.59 | BUY |
| SMA (10) | 47.59 | BUY |
| EMA (20) | 46.82 | BUY |
| SMA (20) | 46.39 | BUY |
| EMA (30) | 46.38 | BUY |
| SMA (30) | 45.91 | BUY |
| EMA (50) | 45.79 | BUY |
| SMA (50) | 45.72 | BUY |
| EMA (100) | 44.80 | BUY |
| SMA (100) | 44.63 | BUY |
| EMA (200) | 43.77 | BUY |
| SMA (200) | 43.08 | BUY |
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.